HK1005189A1 - Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments - Google Patents

Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments Download PDF

Info

Publication number
HK1005189A1
HK1005189A1 HK98104298A HK98104298A HK1005189A1 HK 1005189 A1 HK1005189 A1 HK 1005189A1 HK 98104298 A HK98104298 A HK 98104298A HK 98104298 A HK98104298 A HK 98104298A HK 1005189 A1 HK1005189 A1 HK 1005189A1
Authority
HK
Hong Kong
Prior art keywords
formula
compound
acid compound
acetohydroxamic acid
cyclodextrin
Prior art date
Application number
HK98104298A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1005189B (en
Inventor
Seipp Ulrich
Englberger Werner
Haurand Michael
Schneider Johannes
Original Assignee
Grunenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh
Publication of HK1005189B publication Critical patent/HK1005189B/xx
Publication of HK1005189A1 publication Critical patent/HK1005189A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK98104298A 1991-07-17 1998-05-19 Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments HK1005189A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4123613 1991-07-17
DE4123613A DE4123613C1 (OSRAM) 1991-07-17 1991-07-17

Publications (2)

Publication Number Publication Date
HK1005189B HK1005189B (en) 1998-12-24
HK1005189A1 true HK1005189A1 (en) 1998-12-24

Family

ID=6436313

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104298A HK1005189A1 (en) 1991-07-17 1998-05-19 Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments

Country Status (10)

Country Link
US (1) US5252562A (OSRAM)
EP (1) EP0523499B1 (OSRAM)
AT (1) ATE120460T1 (OSRAM)
AU (1) AU644533B2 (OSRAM)
CA (1) CA2070492A1 (OSRAM)
DE (2) DE4123613C1 (OSRAM)
DK (1) DK0523499T3 (OSRAM)
ES (1) ES2073214T3 (OSRAM)
GR (1) GR3015673T3 (OSRAM)
HK (1) HK1005189A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070111965A1 (en) * 2005-11-15 2007-05-17 Kipp James E Compositions comprising lipoxygenase inhibitors and cyclodextrin
SG175390A1 (en) 2009-04-29 2011-12-29 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686733T2 (de) * 1985-03-16 1993-02-11 Wellcome Found Aryl-derivate.
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
US5026729A (en) * 1987-02-10 1991-06-25 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1316935C (en) * 1987-12-09 1993-04-27 Hiromitsu Saito Hydroxamic acid derivatives
JPH0288553A (ja) * 1988-07-14 1990-03-28 Wellcome Found Ltd:The 抗炎症性アリール誘導体
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
FR2660309B1 (fr) * 1990-03-27 1992-07-17 Roussel Uclaf Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives.

Also Published As

Publication number Publication date
DE59201764D1 (de) 1995-05-04
GR3015673T3 (en) 1995-07-31
ATE120460T1 (de) 1995-04-15
AU2036092A (en) 1993-01-28
ES2073214T3 (es) 1995-08-01
US5252562A (en) 1993-10-12
EP0523499A1 (de) 1993-01-20
CA2070492A1 (en) 1993-01-18
DK0523499T3 (da) 1995-06-12
EP0523499B1 (de) 1995-03-29
AU644533B2 (en) 1993-12-09
DE4123613C1 (OSRAM) 1993-02-04

Similar Documents

Publication Publication Date Title
Linardi et al. Lapachol derivative active against mouse lymphocytic leukemia P-388
EP0606024A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
EP3313816B1 (en) Metabolically robust analogs of cyp-eicosanoids for the treatment of cardiac disease
CA2214744C (en) 3-(bis-substituted phenylmethylene)oxindole derivatives
JPH04300892A (ja) パートリシン誘導体
JPS5829959B2 (ja) パ−トリシン誘導体の製造法
HK1005189A1 (en) Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments
HK1005189B (en) Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments
HK1005179A1 (en) Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation
HK1005179B (en) Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation
US4755525A (en) 2-(fluoroalkyl)-benzimidazoles as inhibitors of 5-lipoxygenase
KR20060092220A (ko) 유도성 ｎｏ-신타아제 저해제로서의 이미다조피리딘 유도체
EP0079639B1 (en) A new anti-inflammatory drug
SK34893A3 (en) Indenindole derivatives, process for their preparation and their pharmaceutical compositions
JPS6339863A (ja) ３−（ヒドロキシメチル）−イソキノリン誘導体およびその酸付加塩、その製造方法、並びにこれを含む薬剤組成物
JPH0514708B2 (OSRAM)
US4542141A (en) Compound having vasodilating, antiaggregating and hypocholesterolemic activities, process for the preparation thereof and pharmaceutical compositions therefrom
US5212201A (en) Xanthine oxidase inhibitor
US4607046A (en) 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate and pharmaceutical compositions
DE4204686A1 (de) Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
NO313413B1 (no) Hydrokinonderivat, anvendelse derav og farmasöytisk preparat
US3971798A (en) Pyridine derivative, processes of preparation and pharmaceutical compositions
JP2025517714A (ja) トリアジンジオン系誘導体の結晶形及び調製方法
EP0446180A1 (en) 5-Phenyl-1H-pyrazol-4-propionic acid derivatives, their preparation and their use
SK287428B6 (sk) Aromatické diketoderiváty, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060706